<DOC>
	<DOCNO>NCT02140580</DOCNO>
	<brief_summary>Trial question : Does administration exogenous surfactant use minimally-invasive technique improve outcome preterm infant 25-28 week gestation treat continuous positive airway pressure ( CPAP ) ? Trial hypothesis : That early surfactant administration via minimally-invasive technique preterm infant CPAP result less duration mechanical respiratory support , high incidence survival without bronchopulmonary dysplasia . Trial design : Multicentre , randomise , mask , control trial inborn preterm infant 25-28 week gestation , age less 6 hour , require CPAP respiratory distress , FiO2 &gt; =0.3 CPAP pressure 5-8 . Infants randomise surfactant treatment receive 200 mg/kg poractant alfa ( Curosurf ) administer direct laryngoscopy use surfactant instillation catheter , follow reinstitution CPAP . Controls continue CPAP . The intervention mask clinical team . Care thereafter per usual group , requirement adhere intubation criterion . The primary outcome incidence death BPD . Secondary outcome include incidence death , major neonatal morbidity ( BPD , intraventricular haemorrhage , periventricular leukomalacia , retinopathy prematurity , necrotising enterocolitis ) , pneumothorax patent ductus arteriosus ; need intubation surfactant therapy ; duration mechanical respiratory support , intubation , CPAP , intubation CPAP , high flow nasal cannula ( HFNC ) , oxygen therapy , intensive care stay hospitalisation ; hospitalisation cost ; applicability safety MIST procedure ; outcome 2 year . The sample size 303/group , allow detection 33 % difference primary outcome 90 % power . The trial commence Royal Hobart Hospital December 2011 Royal Women 's Hospital 2012 , ultimately conduct 5 year multiple centre internationally .</brief_summary>
	<brief_title>OPTIMIST-A Trial : Minimally-invasive Surfactant Therapy Preterm Infants 25-28 Weeks Gestation CPAP</brief_title>
	<detailed_description>1 . OPTIMIST-A TRIAL SUMMARY RESEARCH QUESTION Does administration exogenous surfactant use minimally-invasive technique improve outcome preterm infant 25-28 week gestation treat continuous positive airway pressure ( CPAP ) ? BACKGROUND Nasal CPAP often effective preterm infant initial mean respiratory support , sub-group infant , feature respiratory distress syndrome , fail CPAP require intubation ventilation first 72 hour . When compare CPAP successful , infant fail CPAP substantially long duration respiratory support , high risk adverse outcome . Decreasing risk CPAP failure would thus seem advantageous , may achievable minimally invasive surfactant therapy ( MIST ) , surfactant administer spontaneously breathe infant remain CPAP . A technique MIST ( `` Hobart method '' ) use semi-rigid surfactant instillation catheter show feasible preterm infant CPAP , appear potential alter respiratory course outcome . This method MIST require evaluation randomise controlled trial . RESEARCH DESIGN Multicentre , randomise , mask , control trial . RECRUITMENT Entry criterion Inborn preterm infant 25-28 week gestation , age less 6 hour , intubate birth require CPAP NIPPV respiratory distress , CPAP pressure 5-8 cm H2O FiO2 ≥0.30 . Exclusion criteria Infants exclude imminent need intubation , congenital anomaly alternative cause respiratory distress . RANDOMISATION With parental consent , eligible infant randomly allocate use web-based randomisation server , stratification study centre , receive exogenous surfactant via Hobart MIST technique , continue CPAP . INTERVENTION Infants randomise surfactant treatment receive dose poractant alfa ( Curosurf ) administer direct laryngoscopy use surfactant instillation catheter , dosage 200 mg/kg . CPAP thereafter reinstituted . Controls continue CPAP . The intervention mask clinical team . POST-INTERVENTION MANAGEMENT Other requirement adhere intubation criterion first week , case perform room air trial 36 week correct gestation , management intervention discretion clinical team . Titration CPAP pressure encourage , permit maximum 8 cm H2O . Nasal IPPV ( bi-level CPAP ) allowable . Early caffeine therapy expect . Criteria intubation : Enrolled infant CPAP intubate FiO2 ≥0.45 , unremitting apnoea persistent acidosis . These criterion apply first week life , first episode intubation . FOLLOWUP : At 2 year correct age , parent infant complete brief health assessment validate child development assessment ( PARCA-R , Dev Med Child Neurol 2004 ; 46:389-97 ) administer web-based questionnaire locate secure server . The infant-specific link questionnaire , reminder necessary , send electronically parent research personnel Site , thus maintain confidentiality . No identify detail reveal completion questionnaire . OUTCOMES Primary outcome : Incidence composite outcome death physiological bronchopulmonary dysplasia ( BPD ) . Secondary outcome : Incidence death , major neonatal morbidity ( BPD , intraventricular haemorrhage , periventricular leukomalacia , retinopathy prematurity , necrotising enterocolitis ) , pneumothorax patent ductus arteriosus ; need intubation surfactant therapy ; duration mechanical respiratory support , intubation , CPAP , intubation CPAP , high flow nasal cannula ( HFNC ) , oxygen therapy , intensive care stay hospitalisation ; hospitalisation cost ; applicability safety MIST procedure ; outcome 2 year . SAMPLE SIZE 606 infant ( 303 per group ) , give 90 % power detect 33 % reduction death BPD anticipate rate 38 % control arm , α = 0.05 . TRIAL PLAN The OPTIMIST trial commence RHH Hobart RWH Melbourne 2011 . All Australasian neonatal unit , select international centre include Vermont- Oxford Network , invite join trial . A full complement participate centre expect early 2014 . Recruitment thereafter proceed full rate completion , estimate take 4 year .</detailed_description>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>Gestational age 2528 complete week Requiring CPAP noninvasive positive pressure ventilation sign early respiratory distress . CPAP pressure 58 cm H2O FiO2 &gt; =0.30 . Less 6 hour age . Agreement Treating Physician charge infant 's care . Signed parental consent . Previously intubate , imminent need intubation Congenital anomaly condition might adversely affect breathing . Identifiable alternative cause respiratory distress ( e.g . congenital pneumonia pulmonary hypoplasia ) . Lack availability OPTIMIST treatment team .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Hours</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Minimally-invasive surfactant therapy</keyword>
</DOC>